Fjarde Ap Fonden Edwards Lifesciences Corp Transaction History

Fjarde Ap Fonden

$11.6 Billion
Q3 2025

A detailed history of Fjarde Ap Fonden transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 137,835 shares of EW stock, worth $11.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

137,835

Previous 128,766 7.04%

Holding current value

$11.5 Million

Previous $10.1 Million 6.43%

% of portfolio

0.09%

Previous 0.09%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 28, 2025	BUY	$73.75 - $81.83 $668,838 - $742,116	9,069 Added 7.04%	137,835 $10.7 Million
Q2 2025 Aug 01, 2025	BUY	$67.07 - $78.22 $744,476 - $868,242	11,100 Added 9.43%	128,766 $10.1 Million
Q1 2025 May 13, 2025	BUY	$67.95 - $76.19 $421,290 - $472,378	6,200 Added 5.56%	117,666 $8.53 Million
Q4 2024 Feb 04, 2025	SELL	$64.54 - $75.92 $1.32 Million - $1.56 Million	-20,500 Reduced 15.53%	111,466 $8.25 Million
Q3 2024 Nov 08, 2024	BUY	$59.7 - $93.78 $799,980 - $1.26 Million	13,400 Added 11.3%	131,966 $8.71 Million
Q1 2024 Apr 25, 2024	SELL	$72.54 - $95.56 $493,272 - $649,808	-6,800 Reduced 5.42%	118,566 $11.3 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $438,141 - $552,096	-7,100 Reduced 5.36%	125,366 $9.56 Million
Q3 2023 Oct 23, 2023	SELL	$69.28 - $93.38 $360,256 - $485,576	-5,200 Reduced 3.78%	132,466 $9.18 Million
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $1.1 Million - $1.27 Million	-13,500 Reduced 8.93%	137,666 $13 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $356,448 - $405,648	4,800 Added 3.28%	151,166 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $20,353 - $26,057	298 Added 0.2%	146,366 $10.9 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $69,200 - $102,616	-800 Reduced 0.54%	146,068 $13.9 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $3.12 Million - $3.93 Million	-30,600 Reduced 17.24%	146,868 $17.3 Million
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $337,192 - $414,255	-3,170 Reduced 1.75%	177,468 $23 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $1.06 Million - $1.26 Million	-10,265 Reduced 5.38%	180,638 $20.5 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $544,960 - $680,940	-6,500 Reduced 3.29%	190,903 $19.8 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $519,288 - $598,422	6,600 Added 3.46%	197,403 $16.5 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $422,971 - $538,257	5,900 Added 3.19%	190,803 $17.4 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $403,140 - $524,640	6,000 Added 3.35%	184,903 $14.8 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $6.85 Million - $9.16 Million	119,075 Added 199.03%	178,903 $12.4 Million
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $83,856 - $129,600	-1,600 Reduced 2.6%	59,828 $11.3 Million
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $73,860 - $90,516	-1,200 Reduced 1.92%	61,428 $13.5 Million
Q2 2019 Jul 17, 2019	SELL	$55.74 - $64.41 $33,444 - $38,646	-600 Reduced 0.95%	62,628 $11.6 Million
Q1 2019 Apr 29, 2019	BUY	$47.89 - $64.05 $639,570 - $855,387	13,355 Added 26.78%	63,228 $12.1 Million
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $329,511 - $404,274	-7,100 Reduced 12.46%	49,873 $7.64 Million
Q3 2018 Nov 09, 2018	SELL	$45.7 - $58.03 $71,566 - $90,874	-1,566 Reduced 2.68%	56,973 $9.92 Million
Q2 2018 Jul 12, 2018	BUY	$42.45 - $51.3 $28,993 - $35,037	683 Added 1.18%	58,539 $8.52 Million
Q1 2018 May 07, 2018	BUY	$37.19 - $47.45 $4,388 - $5,599	118 Added 0.2%	57,856 $8.07 Million
Q4 2017 Feb 12, 2018	BUY	$33.79 - $39.39 $270,691 - $315,553	8,011 Added 16.11%	57,738 $6.51 Million
Q3 2017 Nov 07, 2017	SELL	$36.29 - $38.83 $8,419 - $9,008	-232 Reduced 0.46%	49,727 $5.44 Million
Q2 2017 Aug 08, 2017	BUY	N/A	49,959	49,959 $5.91 Million

Others Institutions Holding EW

# of Institutions

1,457

Shares Held

487M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $51.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account